MSCI Appoints Luke Flemmer to Lead and Expand Private Assets Business

In this article:

NEW YORK, October 22, 2024--(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, has appointed Luke Flemmer as Head of Private Assets, effective October 22.

In this role, Flemmer will lead the firm’s Private Assets product development process and be responsible for building, scaling and overseeing MSCI’s Private Assets business. Flemmer is based in New York and will report to Alvise Munari, Chief Product Officer.

Previously, Flemmer served as Managing Director, Head of Digital Strategy for Alternative Investments in the Asset Management Division at Goldman Sachs. Before joining Goldman Sachs in 2020, he was Co-Founder and CEO of Lab49, a global solutions provider of investment and risk technology to the world’s top asset managers and investment banks. Following the acquisition of Lab49 by the ION group in 2015, Flemmer also served as Co-Head of ION’s Capital Markets division, delivering software and solutions to the group’s global financial services customer base and integrating several major acquisitions.

"I am extremely excited by the opportunity to join the leadership team at MSCI to focus on this critical segment of our industry," said Luke Flemmer. "MSCI is uniquely positioned to deliver rigorous and independent data and analytics across all aspects of capital formation, asset selection, and risk and portfolio management. I’m very much looking forward to working with our team and clients to deliver exceptional products in this space."

"Luke is ideally suited to substantially accelerate MSCI’s initiatives in this critical growth area and create solutions that will drive meaningful impact for our clients," said Alvise Munari. "Luke brings invaluable expertise in data and analytics within the financial services sector, along with in-depth knowledge of private assets. His strength in building, growing, and leading companies will be instrumental to our success in building solutions that can help investors understand and navigate the complexities of private markets."

About MSCI Inc.

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data, and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process. To learn more, please visit www.msci.com. MSCI#IR

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or performance and involve risks that may cause actual results or performance differ materially and you should not place undue reliance on them. Risks that could affect results or performance are in MSCI’s Annual Report on Form 10-K for the most recent fiscal year ended on December 31 that is filed with the SEC. MSCI does not undertake to update any forward-looking statements. No information herein constitutes investment advice or should be relied on as such. MSCI grants no right or license to use its products or services without an appropriate license. MSCI MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OTHERWISE WITH RESPECT TO THE INFORMATION HEREIN AND DISCLAIMS ALL LIABILITY TO THE MAXIMUM EXTENT PERMITTED BY LAW.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241022661783/en/

Contacts

Investor Inquiries
jeremy.ulan@msci.com
Jeremy Ulan +1 646 778 4184
jisoo.suh@msci.com
Jisoo Suh +1 917 825 7111

Media Inquiries
PR@msci.com
Melanie Blanco +1 212 981 1049
Konstantinos Makrygiannis +44 (0) 7768 930056
Tina Tan +852 2844 9320

MSCI Global Client Services
EMEA Client Service + 44 20 7618.2222
Americas Client Service +1 888 588 4567 (toll free)
Asia Pacific Client Service + 852 2844 9333

Advertisement